RLYB
Closed
Rallybio Corp
0.3303
-0.0077 (-2.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.338
Day's Range: 0.327 - 0.34
Send
sign up or login to leave a comment!
When Written:
5.01
Rallybio Corp is a biotechnology company that focuses on developing therapies for rare diseases. The company was founded in 2018 and is based in Farmington, Connecticut. Rallybio's mission is to identify and develop transformative therapies for patients with severe and debilitating diseases that currently have limited treatment options. The company's pipeline includes potential treatments for rare diseases such as infantile malignant osteopetrosis, Alagille syndrome, and pyruvate kinase deficiency. In 2020, Rallybio raised $145 million in a Series B funding round to advance its pipeline and expand its team.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








